Skip to content

Effectiveness of Needle and Self-adhesive electro-stimulation in men with Overactive Bladder Syndrome

Eficacy of Percutaneous and Transcutaneous Eletroestimulation in men with Overactive Bladder Syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-6nwvfzd
Enrollment
Unknown
Registered
2024-10-07
Start date
2023-12-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Bladder

Interventions

This is a randomized non-inferiority clinical trial, which will evaluate the non-inferiority of the transcutaneous tibial electrostimulation technique compared to percutaneous electrostimulation in me
E02.331.800

Sponsors

Universidade Federal de São Paulo
Lead Sponsor
Universidade Federal de São Paulo
Collaborator

Eligibility

Sex/Gender
Male
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Male volunteers; over eighteen years of age; diagnosed with overactive bladder syndrome; complaining of urinary urgency

Exclusion criteria

Exclusion criteria: Volunteers with neurological disease; with severe cognitive impairment; with a psychiatric diagnosis; with a cardiac pacemaker; with calculi; with urethral cysts; with an active lower urinary tract infection; diabetic volunteers with signs of peripheral neuropathy; volunteers taking anticholinergics; volunteers with infra bladder obstruction; with bladder cancer or with a metal plate in the lower limbs

Design outcomes

Primary

MeasureTime frame
Improvement of symptoms according to the questionnaires International Consultation on Incontinence Modular Questionnaire - Overactive Bladder Questionnaire

Secondary

MeasureTime frame
No secondary outcomes are expected.

Countries

Brazil

Contacts

Public ContactSilvia Noffs Motta

Universidade Federal de São Paulo

silvianoffs@yahoo.com.br+55 11 985803263

Outcome results

None listed

Source: REBEC (via WHO ICTRP)